Showing 281-290 of 5789 results for "".
Expanded Indications for UltraClear Cold Ablative Fractional Fiber Laser
https://practicaldermatology.com/series/c-suite-chats/expanded-indications-ultraclear-cold-ablative-fractional-fiber-laser/26268/Shlomo Assa, President and Co-Founder of Acclaro Medical, discusses the versatility of the UltraClear Cold Ablative Fractional Fiber Laser, which recently received FDA clearance to treat benign pigmented lesions and vascular dyschromia.Damn The Torpedoes…Full Speed Backwards
https://practicaldermatology.com/columns/editors-message/damn-the-torpedoesfull-speed-backwards/24207/At the Battle of Mobile Bay…warned of mines (called torpedoes) in the water ahead…Farragut said, “Damn the torpedoes! Captain Drayton, go ahead! Jouett, full speed!”Scientifically Speaking: Sunscreen Update from Terri Michele, MD of the FDA CDER
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-sunscreen-update-from-terri-michele-md-of-the-fda-cder/19853/What is the latest on sunscreen labeling? What are implications of recent serology studies? And could new screening agents come to the US market? Host Joel L. Cohen, MD talks to Terri Michele, MD, Director of the Office of Nonprescription Drugs in FDA CDER about these and other hot topics in sun proDERM2020 Exhibitor Reaction: Brett Fair, EPI Health
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-exhibitor-reaction-brett-fair-epi-health/19847/Brett Fair of EPI Health, a DERM2020 exhibitor, tells us what he thinks of the new virtual meeting world and how DEF is dominating it for dermatology!DermWireTV: Meet Crown Aesthetics, Revance to Market Teoxane Fillers, Almirall Collaborates
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-meet-crown-aesthetics-revance-to-market-teoxane-fillers-almirall-collaborates/19719/On the heels of recent acquisitions, Crown Laboratories is reorganizing and rebranding as three divisions: Crown Aesthetics, Crown Beauty, and Crown Therapeutics. Revance gains immediate and exclusive rights to commercialize Teoxane’s RHA 2, RHA 3, and RHA 4 products, which include lidocaine. A fourPerspective: The ABD's Push for Subspecialty Certification in Mohs Surgery Will Fracture Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/perspective-the-abds-push-for-subspecialty-certification-in-mohs-surgery-will-fracture-dermatology/20502/Will SC infringe on the rights of non-certified dermatologists to preform Mohs? Could it lead to reduced exposure to this and other surgical treatments for future dermatologists in training?Focusing on Patient Education in Atopic Dermatitis
https://practicaldermatology.com/topics/practice-management/focusing-on-patient-education-in-atopic-dermatitis/20661/Patients of all ages have atopic dermatitis, and they seek education and support from their dermatologists.Are These Three Weaknesses Lurking In Your LLC Or FLP?
https://practicaldermatology.com/topics/practice-management/are-these-three-weaknesses-lurking-in-your-llc-or-flp/21075/LLCs and FLPs are only as strong or weak as their operating documents and ongoing compliance management.Fillers for the Décolletage Area
https://practicaldermatology.com/topics/practice-management/fillers-for-the-dcolletage-area/21113/Fillers offer patients an alternative to device-based interventions for chest rejuvenation.o, MDAI-based DermGPT Focuses on Improved Clinic Productivity
https://practicaldermatology.com/topics/practice-management/ai-based-dermgpt-focuses-on-improved-clinic-productivity/23990/With Faranak Kamangar, MD; an interview by Heidi W. Moore